These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18555674)

  • 21. Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanisms.
    Burian B; Ortner A; Prassl R; Zimmer A; Mosgoeller W
    Endocr Metab Immune Disord Drug Targets; 2012 Dec; 12(4):344-50. PubMed ID: 23094831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.
    Groneberg DA; Rabe KF; Fischer A
    Eur J Pharmacol; 2006 Mar; 533(1-3):182-94. PubMed ID: 16473346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation.
    Onoue S; Matsui T; Kuriyama K; Ogawa K; Kojo Y; Mizumoto T; Karaki S; Kuwahara A; Yamada S
    Peptides; 2012 Jun; 35(2):182-9. PubMed ID: 22484228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of vasoactive intestinal peptide on the enzyme activity of CTP: phosphorylcholine cytidylyltransferase from the rat lung].
    Guan CX; Zhou FW; Luo ZQ
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):99-101. PubMed ID: 12575328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids.
    Li L; She H; Yue SJ; Qin XQ; Guan CX; Liu HJ; Luo ZQ
    Regul Pept; 2007 May; 140(3):117-24. PubMed ID: 17218027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhalation of a precursor analogue of vasoactive intestinal polypeptide (Leu17 VIP-Gly-Lys) protects ascaris-induced bronchoconstriction in dog].
    Hamada M; Uchida Y; Inoue M; Kameyama M; Nomura A; Ohtsuka M; Itoh O; Tachibana S; Hasegawa S
    Arerugi; 1989 Dec; 38(12):1347-53. PubMed ID: 2634376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ.
    Suzuki H; Noda Y; Gao XP; Séjourné F; Alkan-Onyuksel H; Paul S; Rubinstein I
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H282-7. PubMed ID: 8760186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous administration of SIN-1+VIP in an in vivo rabbit model for erectile function.
    Sazova O; Kadioğlu A; Gürkan L; Kayaarasi Z; Bross S; Manning M; Jünemann KP
    Int J Impot Res; 2002 Feb; 14(1):44-9. PubMed ID: 11896477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the chemical and biological stability of vasoactive intestinal peptide.
    Cui X; Cao D; Qu C; Zhang X; Zheng A
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1907-10. PubMed ID: 22670886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intracerebrally injected aminophylline, vinpocetinum, vasoactive intestinal peptide and onion extract on breathing pattern of rats.
    Vertes C; Debreczeni LA
    Z Erkr Atmungsorgane; 1989; 173(2):134-7. PubMed ID: 2588686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
    Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I
    Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution of liposomal 131I-VIP in rat using gamma camera.
    Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
    Nucl Med Biol; 1999 Nov; 26(8):931-6. PubMed ID: 10708307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respirable powder formulation of a shortened vasoactive intestinal peptide analog for treatment of airway inflammatory diseases.
    Suzuki H; Mizumoto T; Seto Y; Sato H; Onoue S
    J Pept Sci; 2018 Mar; 24(3):. PubMed ID: 29441631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the conformational features of vasoactive intestinal peptide in solution by limited proteolysis experiments.
    Stiuso P; Marabotti A; Facchiano A; Lepretti M; Dicitore A; Ferranti P; Cartenì M
    Biopolymers; 2006 Feb; 81(2):110-9. PubMed ID: 16224772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs.
    Gupta N; Al-Saikhan FI; Patel B; Rashid J; Ahsan F
    Int J Pharm; 2015 Jul; 488(1-2):33-43. PubMed ID: 25888802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocampal asymmetry in exploratory behavior to vasoactive intestinal polypeptide.
    Ivanova M; Ternianov A; Belcheva S; Tashev R; Negrev N; Belcheva I
    Peptides; 2008 Jun; 29(6):940-7. PubMed ID: 18321609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of ischemia/reperfusion-induced accumulation of matrix metalloproteinases in rat lung by preconditioning with nitric oxide.
    Waldow T; Witt W; Buzin A; Ulmer A; Matschke K
    J Surg Res; 2009 Apr; 152(2):198-208. PubMed ID: 18694576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variations of vasoactive intestinal peptide (VIP) concentration in the lung of asthmatic patients].
    Bottino G; Moscatelli P; Antgognozzi G; De Grandi R; Augeri C; Garfagnini A
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):99-102. PubMed ID: 2080314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungs.
    Yin J; Wang L; Yin N; Tabuchi A; Kuppe H; Wolff G; Kuebler WM
    PLoS One; 2013; 8(9):e75861. PubMed ID: 24069452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection.
    Jungraithmayr W; Oberreiter B; De Meester I; Wiedl T; Inci I; Bain M; Augustyns K; Hillinger S; Scharpé S; Weder W; Korom S
    Transplantation; 2009 Aug; 88(4):478-85. PubMed ID: 19696630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.